Cornelia de Lange syndrome: Congenital heart disease in 149 patients

Ariadna Ayerza Casas1, Beatriz Puisac Uriol2, María Esperanza Teresa Rodrigo2

  • 1Unidad de Cardiología Pediátrica, Servicio de Pediatría, Hospital Universitario Miguel Servet, Zaragoza, España; Unidad de Genética Clínica y Genómica Funcional, Departamentos de Farmacología-Fisiología y Servicio de Pediatría del Hospital Clínico Universitario "Lozano Blesa". Facultad de Medicina, Universidad de Zaragoza. Instituto de Investigación Sanitaria (IIS)-Aragón, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)-GCV02, Zaragoza, España.

Medicina Clinica
|June 21, 2017
PubMed

Insights

Congenital heart disease (CHD) affects over a third of Cornelia de Lange syndrome (CdLS) patients, with defect types varying by genetic mutation. Early cardiac evaluation is recommended for all CdLS individuals.

Area of Science:

  • Genetics
  • Cardiology
  • Pediatrics

Background:

  • Cornelia de Lange syndrome (CdLS) is a genetic disorder caused by cohesin complex gene mutations.
  • Congenital heart disease (CHD) is a common but not primary diagnostic feature of CdLS.
  • Understanding CHD incidence and types in CdLS is crucial for patient management.

Purpose of the Study:

  • To determine the incidence and types of congenital heart disease (CHD) in patients with Cornelia de Lange syndrome (CdLS).
  • To investigate the association between CHD and clinical/genetic variables in CdLS patients.

Main Methods:

  • Retrospective analysis of cardiological findings in 149 CdLS patients.
  • Correlation of CHD presence with clinical data and specific gene mutations (HDAC8, NIPBL, SMC1A).

Main Results:

  • 34.9% of CdLS patients had CHD, primarily septal defects (50%), pulmonary stenosis (27%), and aortic coarctation (9.6%).
  • CHD was linked to neonatal hospitalization, hearing loss, mortality, and reduced hyperactivity.
  • Incidence varied by gene: HDAC8+ (60%), NIPBL+ (33%), SMC1A+ (28.5%), with distinct defect patterns.

Conclusions:

  • CdLS patients exhibit a high prevalence of CHD, influenced by the specific gene mutation.
  • Septal defects and pulmonary stenosis are the most common CHD types in this population.
  • Routine cardiological assessment is advised for all individuals diagnosed with CdLS.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
673
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
956
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
782
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
360